BDBM42468 2-[2-azanylidene-3-[(4-chlorophenyl)methyl]benzimidazol-1-yl]-1-(furan-2-yl)ethanol;hydrochloride::2-[3-(4-chlorobenzyl)-2-imino-benzimidazol-1-yl]-1-(2-furyl)ethanol;hydrochloride::2-[3-[(4-chlorophenyl)methyl]-2-imino-1-benzimidazolyl]-1-(2-furanyl)ethanol;hydrochloride::2-[3-[(4-chlorophenyl)methyl]-2-iminobenzimidazol-1-yl]-1-(furan-2-yl)ethanol;hydrochloride::CHEMBL1624727::MLS000039011::SMR000034300::cid_6602706

SMILES OC(Cn1c2ccccc2n(Cc2ccc(Cl)cc2)c1=N)c1ccco1

InChI Key InChIKey=SLBPOUTXKRGMHU-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 42468   

TargetSodium/glucose cotransporter 2(Human)
National Health Research Institutes

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 42468BDBM42468(cid_6602706 | CHEMBL1624727 | 2-[3-[(4-chloropheny...)
Affinity DataEC50:  1.10E+4nMAssay Description:Inhibition of human SGLT2 expressed in CHO-K1 cells assessed as reduction in [14C]-alpha-methylglucopyranoside uptake after 2 hrs by liquid scintilla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/6/2011
Entry Details Article
PubMed